April 09, 2021
Article
The first step toward operationalizing the uptake of biosimilars is having a program-level discussion that not only describes what biosimilars are, but also assesses how they impact the bottom line and could get incorporated into treatment plans.
The discovery points to a novel treatment target for shrinking brain tumors that arise secondary to breast cancer, according to the study authors.
Pharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.
Trepanning is one of the oldest known forms of surgery that was historically used to address issues pertaining to the skull.
Opdivo-based combinations show benefit for patients with esophageal cancer who are often diagnosed after their disease has spread and would benefit from new therapeutic options.
Video
Megan May, PharmD, BCOP, Cecilia Lau, RPh, BCOP, APh, and Daneng Li, MD, share their thoughts on unmet needs in the management of neuroendocrine tumors.
April 08, 2021
A session at the Community Oncology Alliance virtual 2021 conference noted that clinical trials have found promising new treatments for patients with breast cancer, offering opportunities for future new approvals and indications.
Developing an antimicrobial stewardship program is arduous but valuable; commitment from leadership is the first step.
In patients who received early palliative care, researchers noted a lower percentage of patients with depression, improved quality of life, and, significantly, longer survival.
Panelists at the Community Oncology Alliance (COA) virtual 2021 conference said the impacts of the pandemic on their day-to-day operations were challenging, although they all said they were proud of how their staff handled the rapid changes in spring of 2020.
